The opioid epidemic has drawn nationwide attention and has engaged leaders in the public and private sectors to address prevention and treatment. Cigna is fully engaged in this cause and has committed to reducing the overall consumption of opioids by 25% in the next 3 years*.
Click here for a replay of the webinar (use case-sensitive password Cigna1) to gain an inside look at efforts on prevention, evidence-based treatment, and how reducing the stigma of opioid abuse disorder will increase the number of people who seek treatment. Cigna's Dr. Douglas Nemecek and Michael Arvesen, Pharm.D, discuss the specific ways in which connected benefits – behavioral, medical and pharmacy – help ensure high-risk customers for overdose are identified and engaged in effective treatment.
*For U.S. Commercial and Cigna-HealthSpring customers